Connect with us

Business

Third member of US FDA advisory panel resigns over Alzheimer’s drug approval – Fox Business

Published

on

Article feature image
ADVERTISEMENT

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s decision to approve Biogen Inc’s Alzheimer’s disease treatment despite the committee’s recommendation against doing so.
Aaron…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Reports of Mining Sector Cleanup Put China’s Yunnan Province in the Spotlight – Mining Bitcoin News – Bitcoin News
Article feature image
Northrop Grumman’s Pegasus rocket launches US Space Force mission – SpaceNews
Article feature image
Musk Says Tesla to Use Bitcoin Transactions When Mining Cleaner – Yahoo Finance